Sign in

CIK 0001599298 · Large accelerated filer

Summit Therapeutics Inc.

Sign in to watch
Ticker
SMMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
371979717
Phone
305-203-2034
Business address
601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
Former names
Summit Therapeutics plc, Summit Corp plc
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $2.07 ($10,350)
  7. 4 Open-market buy Chief Financial Officer bought 20,400 shares at an average $2.17 ($44,254)
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy Chief Operating Officer bought 2,976,190 shares at $1.68 ($4,999,999)
  10. 4/A Open-market buy Co-CEO & President bought 23,527,044 shares at $1.05 ($24,703,396)
  11. 4 Open-market buy Co-Chief Executive Officer bought 23,527,044 shares at $1.05 ($24,703,396)
  12. 4 Open-market buy Chief Financial Officer bought 196,362 shares at $1.05 ($206,180)
  13. 4/A Open-market buy Chief Financial Officer bought 37,685 shares at $0.97 ($36,554)
  14. 4 Open-market buy Chief Executive Officer bought 376,489,880 shares at $1.05 ($395,314,374)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 7 · 130 filings